Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families

Breast Cancer Research : BCR
Geoffrey J LindemanJudy Kirk

Abstract

Germline mutations in the genes BRCA1 and BRCA2 account for only a proportion of hereditary breast cancer, suggesting that additional genes contribute to hereditary breast cancer. Recently a heterozygous variant in the ataxia-telangiectasia mutated (ATM) gene, IVS10-6T-->G, was reported by an Australian multiple-case breast cancer family cohort study (the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer) to confer a substantial breast cancer risk. Although this variant can result in a truncated ATM product, its clinical significance as a high-penetrance breast cancer allele or its role as a low-penetrance risk-modifier is controversial. We determined the frequency of ATM IVS10-6T-->G variants in a cohort of individuals affected by breast and/or ovarian cancer who underwent BRCA1 and BRCA2 genetic testing at four major Australian familial cancer clinics. Seven of 495 patients (1.4%) were heterozygous for the IVS10-6T-->G variant; the carrier rate in unselected Australian women with no family history of breast cancer is reported to be 6 of 725 (0.83%) (P = 0.4). Two of the seven probands also harboured a pathogenic BRCA1 mutation and one patient had a BRCA1 unclassified variant of uncertain signif...Continue Reading

References

Dec 26, 1991·The New England Journal of Medicine·M SwiftC L Chase
May 21, 1987·The New England Journal of Medicine·M SwiftC L Chase
Mar 1, 1997·Nature Genetics·M G FitzGeraldD A Haber
Mar 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O T JóhannssonH Olsson
Mar 31, 1999·British Journal of Cancer·H M InskipC F Arlett
Mar 21, 2000·American Journal of Human Genetics·A BroeksL J van 't Veer
Feb 24, 2001·Journal of the National Cancer Institute·J H OlsenM Tucker
Mar 10, 2001·Nature Genetics·K K Khanna, S P Jackson
Jun 19, 2001·International Journal of Cancer. Journal International Du Cancer·B Geoffroy-PerezN Andrieu
Feb 7, 2002·Journal of the National Cancer Institute·Georgia Chenevix-TrenchKum Kum Khanna
May 9, 2002·Cancer Genetics and Cytogenetics·Steve S SommerAnatoly Dritschilo
Jun 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Donald A BerryGiovanni Parmigiani
Jun 20, 2002·Journal of the National Cancer Institute·Haixin LeiIgor Vorechovsky
Mar 4, 2003·Nature Reviews. Cancer·Yosef Shiloh
Apr 4, 2003·Human Mutation·Annegien BroeksLaura J van't Veer
May 30, 2003·The EMBO Journal·Nicolas ForayPenny Jeggo
Oct 17, 2003·British Journal of Cancer·J L BernsteinUNKNOWN WECARE Study Collaborative Group
Feb 12, 2004·Cancer Research·Csilla I SzaboHanne Meijers-Heijboer
Dec 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Teresa PuigRamon Colomer

❮ Previous
Next ❯

Citations

Sep 26, 2006·Oncogene·M Ahmed, N Rahman
Aug 18, 2006·BMC Cancer·Johanna TommiskaHeli Nevanlinna
Apr 8, 2009·Genome Medicine·Roger L Milne
Mar 3, 2007·Breast Cancer Research and Treatment·Ariel E HirschBarry S Rosenstein
May 2, 2006·Obstetrics and Gynecology·Katherine BiancoMary E Norton
Jun 20, 2013·Oncology Reports·Hiroshi KobayashiMiyuki Matsuura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Journal of the National Cancer Institute
Georgia Chenevix-TrenchKum Kum Khanna
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Nancy UhrhammerYves-Jean Bignon
© 2022 Meta ULC. All rights reserved